JAG2 and cancer: The results revealed a heterogeneous co-expression pattern of JAG2 and EMT markers, i.e., in 2 of the 6 tissues, JAG2 was highly expressed in and no difference in the expression of EMT markers was found between the cancer tissues and the adjacent tissues (Fig. 4).